Abstract. Norcantharidin (NCTD) is one of the ingredients of blister beetles which have been used in Chinese medicine for a long time. The purpose of this study was to investigate the inhibitory effects of NCTD on TSGH 8301 human bladder cancer cells in vitro and the mechanisms through which it exerts its anticancer action. Cell morphological analysis was performed using a phase-contrast microscope. The percentage of viable cells, cell cycle distribution, sub-G1 phase (apoptosis), reactive oxygen species (ROS) production and the levels of mitochondrial membrane potential (∆Ψ m ) were analyzed by flow cytometry. DNA condensation and damage were determined by DAPI staining and comet assay. Apoptosisassociated protein level changes in TSGH 8301 cells following exposure to NCTD were examined, measured and determined by western blotting. Analysis of protein translocation was conducted by immunostaining and confocal laser microscopy. The results indicated that NCTD promoted cytotoxic effects, including the induction of cell morphological changes and the decrease in the percentage of viability, the induction of S-phase arrest as well as sub-G1 phase (apoptosis) in TSGH 8301 cells. The activities of caspase-3 and -9 were upregulated following NCTD treatment. Western blotting indicated that NCTD upregulated Fas, FasL, Bax, Bid, cytochrome c, caspase-3, -8 and -9 that led to the induction of apoptosis through the Fas extrinsic pathway. Furthermore, NCTD induced AIF and Endo G that were released from mitochondria to induce apoptosis through the mitochondrial-independent pathway. NCTD upregulated ROS production, downregulated ∆Ψ m and ERK, JNK, p38 protein kinases in TSGH 8301 cells. These findings suggest that NCTD triggers apoptosis in TSGH 8301 human bladder cancer cells via the Fas receptor, activation of the caspse-8, -9 and -3, mitochondrial-dependent and -independent pathways. NCTD may be useful for developing new therapeutic regimens for the treatment of bladder cancer.
Introduction
Bladder cancer is one of the leading causes of mortality in humans worldwide. Bladder cancer is the fourth most common malignancy in men and the ninth most common in women in United States (1) . In Taiwan, about 3.2 per 100,000 individuals succumb to the disease annually, according to the 2010 report from the Department of Health, R.O.C. (Taiwan). Currently, the treatments for bladder cancer remain unsatisfactory, therefore, numerous studies have focused on finding or synthesizing new compounds and on investigating the molecular mechanisms of action from bioactive compounds in order to develop chemoprevented and/or therapeutic agents (2) .
One of the best ways for anticancer agents to treat cancer is to induce cell apoptosis. The characteristic morphological and biochemical changes of apoptosis are mediated by a series of gene regulation and cell-signaling pathways, including the extrinsic pathway (3, 4) which is triggered via specific ligand and surface receptors CD95/Fas, tumor necrosis factor (TNF) and death receptors (3) (4) (5) ; the intrinsic pathway, which is induced via DNA damage, cellular distress, hypoxia and cytotoxic agents (4, 6) ; and the endoplasmic reticulum (ER) stress pathway via the interaction between the mitochondria and the ER (7).
Mylabris (Chinese blistering beetle) such as Mylabris phalerata Pall. and M. cichorii Linn was mostly used in medicine and it is still used as a folk medicine today (8) . The active constituent of mylabris is cantharidin (9) . Norcantharidin (NCTD) is the demethylated analog of cantharidin isolated from natural blister beetles (10) . NCTD induces apoptosis in hepatoma cells (11) , inhibits tumor cell growth, invasion, and metastasis in nude mice bearing human gallbladder carcinoma (12) and it also induces cytotoxicity in HepG2 cells by apoptosis, which is mediated through reactive oxygen species (ROS) generation and the mitochondrial pathway (13) . Furthermore, numerous studies have reported that NCTD inhibits angiogenesis and breast cancer cell line metastases without significant renal or liver toxicity (10, (14) (15) (16) (17) (18) .
However, the inhibitory activities of NCTD against human bladder cancer cells remains unclear. In this study, we investigated the in vitro effects of NCTD on the growth of the human bladder cancer cell line TSGH 8301. We investigated the molecular mechanisms of action of NCTD on ROS production associated with the induction of apoptosis and its downstream targets.
Materials and methods
Chemicals and reagents. Norcantharidin, dimethyl sulfoxide (DMSO), potassium phosphates, propidium iodide (PI), Tris-HCl, trypan blue and ribonuclease-A (RNase A), were obtained from Sigma-Aldrich Corp. (St. Louis, MO, USA). RPMI-1640 medium, L-glutamine, fetal bovine serum (FBS), penicillin-streptomycin, and trypsin-EDTA were obtained from Gibco/Life Technologies (Grand Island, NY, USA). Norcantharidin was prepared in DMSO and stored as small aliquots at -20˚C. Anti-p21 (Cat. 05-345), anti-p53 (Cat. 04-241) and anti-Bax (Cat. 04-434) were bought from Merck Millipore (Bedford, MA, USA). The other primary antibodies used in this study were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Cell culture. The TSGH 8301 human bladder carcinoma cells were purchased from the Food Industry Research and Development Institute (Hsinchu, Taiwan). TSGH 8301 cells were maintained on 75 cm 2 tissue culture flasks with RPMI-1640 medium with 10% FBS and 1.5 mM L-glutamine were adjusted to contain 1.5 µg/ml sodium bicarbonate and 1% penicillinstreptomycin (100 U/ml penicillin and 100 µg/ml streptomycin) and grown at 37˚C under a humidified 5% CO 2 atmosphere (18).
Cell morphology, viability, cell cycle distribution and apoptosis assays. TSGH 8301 cells were seeded in a 12-well plate at a concentration of 2x10 5 cells/well overnight and were then incubated with 0, 10, 20, 30, 40 and 50 µM of NCTD at 37˚C, 5% CO 2 and 95% air for 24 and 48 h. Cells were examined and photographed under a phase-contrast microscope at x200 for morphological changes. Then, cells in each well were harvested and stained with PI (5 µg/ml) and the total percentage of viable cells in all samples was measured by flow cytometry (Becton-Dickinson, San Jose, CA, USA), as previously described (18, 19) . For cell cycle distribution and sub-G1 (apoptosis) determination, isolated cells from each treatment were fixed gently by putting 70% ethanol at 4˚C overnight and then re-suspended in PBS containing 40 µg/ml PI and 0.1 mg/ml RNase and 0.1%Triton X-100 in the dark for 30 min at 37˚C; the cells were then analyzed with a flow cytometer equipped with an argon ion laser at 488 nm wavelength (18, 19) . In order to confirm whether or not NCTD induces cell morphological changes and decreases the total percentage of viable TSGH 8301 cells, cells were pretreated with NAC, and were then treated with NCTD and cell morphological changes and total viable cells were measured as described above.
DNA damage measured by DAPI staining and comet assay.

Approximately 2x10
5 cells/ml of TSGH 8301 cells in a 12-well plate were individually treated with 0, 10, 20, 30, 40 and 50 µM of NCTD for 24 h. For DAPI staining, cells in each treatment were stained with DAPI (4,6-diamidino-2-phenylindole dihydrochloride), and were then examined and photographed using a fluorescence microscope as previously described (19) (20) (21) . For the comet assay, cells from each treatment were harvested by centrifugation, isolated and examined for DNA damage using the comet assay as previously described (19) (20) (21) . harvested by centrifugation and re-suspended in 500 µl of 2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) (10 µM) for ROS, in 500 µl of DiOC 6 (1 µM) for ∆Ψ m and in 500 µl of PhiPhiLux-G1D2 substrate (25 µM) for caspase-3 activity determination, as previously described (19) (20) (21) . Cells from each treatment were incubated at 37˚C for 30 min before being analyzed by flow cytometry as previously described (19) (20) (21) , or cells in each treatment were pretreated with NAC and then treated with NCTD for 24 h before being harvested to measure the ROS and NAO productions, the levels of ∆Ψ m and catalase expression.
Detections of ROS
Determination of cell cycle and apoptosis-associated proteins by western blotting. Approximately 5x10
5 cells of TSGH 8301 cells were maintained in a 6-well plate and then treated with 20 µM NCTD for 0, 6, 12, 24, 48 and 72 h. Cells from each treatment were harvested in tube with lysis buffer containing 40 mM Tris-HCl (pH 7.4), 10 mM EDTA, 120 mM NaCl, 1 mM dithiothreitol, 0.1% Nonidet P-40 and total proteins were quantified as previously described (19) (20) (21) . Total proteins (30 µg) from each treatment were individually loaded into the gel for western blot analysis and all samples were performed using 10% Tris-glycine-SDS-polyacrylamide gels for 30 min. The proteins were then transferred to a nitrocellulose membrane by electroblotting (19) (20) (21) . The transferred membranes were incubated with primary antibodies as follows: i) p27, p21 and p53; ii) caspase-8, -9 and -3; iii) Bax and Bid; iv) AIF, Endo G and cytochrome c; v) Fas and FasL; vi) p-ERK, JNK and p-p38 and were washed before being incubated with a secondary antibody for enhanced chemiluminescence (NEN Life Science Products, Inc, Boston, MA, USA) as previously described (19) (20) (21) . Anti-β-actin (a mouse monoclonal antibody) was used as a loading control.
Confocal laser scanning microscopy shows protein translocation in TSGH 8301 cells. TSGH 8301 cells (5x10
4 cells/well) were cultured on 4-well chamber slides and were then treated with or without 20 µM NCTD for 24 h. Cells on the slides were fixed in 4% formaldehyde in PBS for 15 min, permeabilized with 0.3% Triton-X 100 in PBS for 1 h with blocking of non-specific binding sites using 2% BSA as previously described (21) . Primary antibodies to AIF and Endo G (1:100 dilution) (green fluorescence) were used to stain the fixed cells overnight and were then washed twice with PBS and stained with secondary antibody (FITC-conjugated goat anti-mouse IgG at 1:100 dilution), followed by DNA staining with mitotracker (red fluorescence) as previously described (21) . All samples were photomicrographed and were obtained using a Leica TCS SP2 Confocal Spectral Microscope (21) .
Statistical analysis. The results in this study are shown as the mean ± SD and the difference between the NCTD-treated and control groups were analyzed by Student's t-test; a probability of P<0.05 was considered significant.
Results
Effects of NCTD on cell morphology, viability, cell cycle distribution and sub-G1 phase in TSGH 8301 cells. The effects of the growth inhibition of NCTD on TSGH 8301 cells were examined; the morphological changes were observed under a phase-contrast microscope, viability, cell cycle distribution and sub-G1 (apoptosis) were examined by flow cytometric assay and the results are shown in Fig. 1A-C and Fig. 2A and B . Increasing the concentrations of NCTD and/or the time (Fig. 1A and B) and a decrease in the percentage of viability (Fig. 1C) . NCTD (20 µM) significantly decreased by almost 48% the viable cells at 48 h treatment. Fig. 2A and B show that TSGH 8301 cells were exposed to 20 µM of NCTD for various intervals of time increased the percentage of cells in S phase in a time-dependent manner. Furthermore, the sub-G1 groups (apoptosis) also appeared in the cell cycle distribution and these effects are time-dependent.
Effects of NCTD on DNA condensation and damage in TSGH 8301 cells. The effects of NCTD on DNA damage of TSGH 8301 cells were examined by comet assay and DAPI staining. The TSGH 3801 cells were treated with various concentrations of NCTD for 24 h and then isolated for DAPI staining and comet assay. The results are presented in Fig. 3A and B and indicate that NCTD induced DNA condensation and decreased the cell number (Fig. 3A) and also induced DNA damage (Fig. 3B) production, mitochondrial and caspase-3 pathway, TSGH 8301 cells were treated with 20 µM NCTD for various time periods. The levels of ROS production, ∆Ψ m and caspase-3 activity were measured and determined by flow cytometric assay (Fig. 4A-C) . Fig. 3 shows NCTD increased the production of ROS (Fig. 4A) and decreased the levels of ∆Ψ m (Fig. 4B) , compared with the control group. Fig. 4C also shows that NCTD induced the activity of caspase-3 in TSGH 8301 cells.
NAC pretreatment affects NCTD-induced morphological changes, viability, reactive oxygen species (ROS) production, the levels of mitochondrial membrane potential (∆Ψ m ) and NAO and catalase productions in TSGH 8301 cells.
To confirm the role of ROS in NCTD-induced cell death in TSGH 8301 cells, the cells were pretreated with ROS scavenger (N-acetyl cystein, NAC) and were then treated with 20 µM NCTD for 24 h. The cells were then examined for cell morphological changes (Fig. 5A) , total percentage of viable cells (Fig. 5B) , ROS production (Fig. 5C ), the levels of ∆Ψ m (Fig. 5D) , and NAO production (Fig. 5E ). Fig. 5 shows that after cells were pretreated with NAC, there was a decrease in cell morphological changes (Fig. 5A) , an increase in the viable cell number (Fig. 5B) , a decrease in the ROS production (Fig. 5C ) and an increase in the levels of ∆Ψ m (Fig. 5D) , but no significant effect on NAO production in TSGH 8301 cells. Fig. 5F shows that TSGH 8301 cells following treatment with NCTD led to an increase in the catalase expression time-dependently.
Effects of NCTD on the associated protein levels of apoptosis in TSGH 8301 cells.
In order to investigate NCTD-induced apoptosis through the possible signaling pathways in TSGH 8301 cells, the cells were treated with 20 µM of NCTD for various time periods and the protein levels were analyzed by western blotting. Results are shown in Fig. 6 , where NCTD increased the levels of p27, p21 and p53 (Fig. 6A) , caspase-8, -9, -3 ( Fig. 6B ), Bax and Bid (Fig. 6C) , AIF, Endo G and cytochrome c (Fig. 6D ), Fas and FasL (Fig. 6E ) and p-ERK and p-p38 (Fig. 6F ) but decreased the levels of p-JNK (Fig. 6F) in TSGH 8301 cells leading to apoptosis. Thus, we suggest that NCTD-induced apoptosis is mediated by the mitochondrial and ROS-induced ER stress pathways.
Effects of NCTD on the apoptosis-associated protein translocation in TSGH 8301 cells.
In order to confirm that NCTD affected the apoptosis-associated protein translocation in TSGH 8301 cells, 5x10 4 cells/well were plated on 4-well chamber slides, were then treated with 20 µM NCTD for 24 h and then stained by primary and secondary antibodies and examined and photographed by confocal laser microscopic systems. The results are presented in Fig. 7A and B, the photographs demonstrate that after the merge, Endo G (Fig. 7A) and AIF (Fig. 7B ) are released from mitochondria, then translocate to the nuclei evidenced by the nuclei colors already changing to orange, indicating that the proteins have migrated to the nuclei. Furthermore, based on the double immuno-fluorescence labelling it was confirmed by means of confocal scanning microscopy that the Endo G and AIF were increased following exposure to NCTD in TSGH 8301 cells. 
Discussion
We present results from several observations, demonstrating that NCTD induces apoptosis in TSGH 8301 bladder cancer cells and also show its possible associated mechanism. TSGH 8301 cells treated with NCTD displayed PI-or DAPI-stained condensed nuclei and a sub-G1 DNA phase of PI-stained nuclei analyzed by flow cytometry. Fig. 2 indicates that the number of S-phase cells increased when the number of apoptotic cells increased, as a result of treatment with NCTD. However, there was an apparent decrease in the number of G 0 /G 1 and G 2 /M phase cells within 72 h. With an increase in the NCTD treatment time, the number of G 0 /G 1 and G 2 /M phase cells gradually decreased and the Sub-G 1 cells increased ( Fig. 2A and B) . This is not in agreement with other reports demonstrating that NCTD may cause rapid apoptosis in S-phase cells and delayed apoptosis in G 2 /M arrested cells of colorectal cancer cells (9) due to the differences of cancer cells.
The results of this study show that NCTD decreased viable cells and induced S-phase arrest (Fig. 2) . Fig. 6A also shows that NCTD increased the levels of p53, p27 and p21 that may lead to S-phase arrest. NCTD induced apoptosis based on DAPI-staining and Sub-G 1 phase in cell cycle analysis of TSGH 8301 cells. Flow cytometric assay also showed NCTD promoted caspase-3 activation (Fig. 4C) that was confirmed by western blotting (Fig. 6B) demonstrating that NCTD promoted activist form of caspase-8, caspase-3 and caspase-9 (Fig. 6B) . It is well known that apoptosis can be divided into caspasedependent-and -independent signal pathways (22, 23) . Thus, the NCTD induced apoptosis in TSGH 8301 cells was via the caspase-dependent pathway. It has been reported that Fas and Fas ligand activation are involved in drug-induced apoptosis in solid cancer and leukemia cell lines (24) . Our results from western blotting (Fig. 6C) indicate that NCTD promoted Fas and FasL in TSGH 8301 cells. NCTD-induced apoptosis may be through the Fas and FasL pathway. This is in agreement with other reports demonstrating that NCTD-treated cells show the activation of caspase-8, which has been found to be a prominent signaling caspase involved in the initiation of apoptosis by CD95 (9, 25, 26) .
Flow cytometric assay also showed that NCTD promoted ROS production and decreased the levels of ∆Ψ m (Fig. 4A and B) . This is in agreement with another study indicating that NCTD induced cytotoxicity in human liver cancer HepG2 cells by apoptosis, which is mediated through ROS generation and the mitochondrial pathway (13) . It has been reported that agents decreased the levels of ∆Ψ m which may lead to apoptosis in cancer cells through the mitochondria-dependent pathway (13) which are involved in AIF, Endo G release from mitochondria and lead to apoptosis via the caspase-independent pathway (27) . Herein, our results also show that NCTD promoted the expression of AIF and Endo G (Fig. 6D) as confirmed by the confocal laser system microscope ( Fig. 7A and B) . These novel findings may suggest that NCTD-induced apoptosis in TSGH 8301 cells may occur via the caspase-dependent, -independent and mitochondrialdependent pathways. Our results show that NCTD promoted Bax and BID levels (Fig. 6E) . Numerous studies have shown that some Bax, Bcl-XL, Mcl-1, Bcl-2, and Bid are located on the mitochondrial membrane; they can alter the permeability of the mitochondrial membrane causing the activation of caspases leading to apoptosis (28) (29) (30) . This is in agreement with other reports that show that NCTD inhibited the in vitro and ex vivo growth of human lung cancer A549 cells and regulated the expression of Bcl-2 and Bax proteins in a dosedependent manner (14) .
Our results in Fig. 4A show that NCTD promoted the production of ROS in TSGH 8301 cells. Furthermore, pretreatment of cells with NAC followed by NCTD led to NCTD-induced increase in ROS that can be abolished or attenuated by NAC (antioxidant). This is in agreement with other reports indicating that the NCTD-induced increase in ROS and anti-proliferation of human liver cancer HepG2 cells are apparently dependent on ROS generation (14) . Thus, in the present study, our results demonstrate that NCTD promotes ROS production and a decrease in the levels of ∆Ψ m , leading to apoptosis. Other reports have shown that cancer cells after being exposed to anticancer agents led to the generation of ROS contributing to mitochondrial damage and then leading to cell death by acting as an apoptotic signaling molecule (31, 32) . In the present study, ERK, JNK, and p38 were all found to be activated in TSGH 8301 cells following exposure to NCTD. Thus, NCTD-induced cytotoxicity could be due to the induced JNK activation in TSGH 8301 cells.
In conclusion, based on the above results NCTD efficiently inhibited the growth of TSGH 8301 human bladder cancer cells via the Fas receptor leading to caspase-3 activation for apoptosis known as mitochondria-independent and to other pathways through mitochondria-dependent signal pathways to the release of AIF and Endo G causing apoptosis. The possible signal pathways of NCTD-induced apoptosis in TSGH 8301 cells is shown in Fig. 8 . Further investigation on both in vivo and in vitro bladder cancer models is required.
